Download MendeleyThe role of kinase domain dimerization in EGFR activation.
Petrova, Z.O., Han, L., Tsutsui, Y., Sheetz, J.B., Ashtekar, K.D., Lemmon, M.A.(2026) Structure 34: 426-440.e6
- PubMed: 41421344 Search on PubMedSearch on PubMed Central
- DOI: https://doi.org/10.1016/j.str.2025.11.017
- Primary Citation Related Structures:
9P9U - PubMed Abstract:
The epidermal growth factor receptor (EGFR) was among the first receptor tyrosine kinases (RTKs) shown to be activated by ligand-induced dimerization. Structural studies explain how ligand binding induces the dimerization of EGFR's extracellular region. Unlike other RTKs, EGFR's intracellular tyrosine kinase domain (TKD) is activated allosterically in an asymmetric dimer that is observed crystallographically, but not in cryo-EM studies of intact EGFR. Here, we show that this asymmetric TKD dimer forms only transiently - explaining its lack of definition by cryo-EM. By engineering an asymmetric TKD dimer and studying a TKD-duplicated lung cancer EGFR variant, we show that TKD dimerization increases kinase activity by several hundred-fold. We were also able to stabilize and visualize discrete asymmetric EGFR TKD dimers at high resolution using cryo-EM. Our findings argue that oncogenic mutations activate EGFR primarily by promoting TKD dimerization, and suggest that the transient nature of EGFR TKD dimers may allow biased EGFR signaling.
- Department of Pharmacology, Yale University School of Medicine, New Haven, CT 06520, USA; Yale Cancer Biology Institute, Yale University West Campus, West Haven, CT 06516, USA.
Organizational Affiliation:
